Description: Diagnostic and Natural History Markers in Amyotrophic Lateral Sclerosis

We have been awarded a National Institute of Health grant to investigate establishment of biological, diagnostic and natural history markers in ALS. The project will investigate the use of novel technologies to identify these types of markers.

This will be very helpful for clinical trials and is the first comprehensive investigation that seeks to identify diagnostic and natural history markers in ALS. We believe that our study will expand understanding of the pathophysiology of ALS. The results of our project will permit effective clinical trials with increasing numbers of potential therapeutic agents and eventually improve the diagnosis and care of patients with this disease.

If you are interested, please call (212) 305-1319 or email ALSCenter@columbia.edu.

Clinical Trials at our Center